Board of Directors

176

John M. Burke, PhD

Co-Founder, President and CEO
Dr. Burke’s BS and MS are in Applied Mathematics from the University of Massachusetts, Lowell, in 1993 and 1995, respectively. His PhD degree is in Applied Mathematics from Arizona State University in 2003. His research interests include singularly and randomly perturbed differential equations, bifurcation theory, and applying dynamical systems theory to study and understand how cells and tissues make decisions in humans, and human disease. Prior to co-founding Applied BioMath, Dr. Burke joined... Read More
182

Joshua Apgar, PhD

Co-Founder and CSO
Before co-founding Applied BioMath, Josh was a Principal Scientist in the Systems Biology Group of the Department of Immunology and Inflammation at Boehringer Ingelheim Pharmaceuticals. His work leveraged physics-based models to: translate in vitro and in vivo data, assess target feasibility, understand drug mechanism of action, and predict human doses. The ultimate goal of this work was to reduce late stage attrition in drug development through a deep and quantitative interrogation of drug... Read More
186

Andrew Sutherland, MSc

Co-Founder and CFO
Andrew brings over 18 years of experience in growing and developing financial and operational processes to Applied BioMath. As one of the co-founders, Andrew is responsible for all business matters at Applied BioMath. He has a long track record of successfully driving shareholder value and most recently was head of finance and administration at Litle & Co., which was acquired by Vantiv in 2012. Prior to Litle, Andrew worked for a number of startups, all in finance and administration roles.... Read More
203

Vihann Kong

Manager, Demand Response New England
Constellation an Exelon Company
204

Peter Sorger, PhD

Otto Krayer Professor of Systems Pharmacology,
Head of the Program in Therapeutic Science, Harvard Medical School

Science Advisory Board

176

John M. Burke, PhD

Co-Founder, President and CEO
Dr. Burke’s BS and MS are in Applied Mathematics from the University of Massachusetts, Lowell, in 1993 and 1995, respectively. His PhD degree is in Applied Mathematics from Arizona State University in 2003. His research interests include singularly and randomly perturbed differential equations, bifurcation theory, and applying dynamical systems theory to study and understand how cells and tissues make decisions in humans, and human disease. Prior to co-founding Applied BioMath, Dr. Burke joined... Read More
182

Joshua Apgar, PhD

Co-Founder and CSO
Before co-founding Applied BioMath, Josh was a Principal Scientist in the Systems Biology Group of the Department of Immunology and Inflammation at Boehringer Ingelheim Pharmaceuticals. His work leveraged physics-based models to: translate in vitro and in vivo data, assess target feasibility, understand drug mechanism of action, and predict human doses. The ultimate goal of this work was to reduce late stage attrition in drug development through a deep and quantitative interrogation of drug... Read More
206

Doug Lauffenburger, PhD (SAB Chair)

Ford Professor of Biological Engineering, Chemical Engineering and Biology
Head of the Department of Biological Engineering, Massachusetts Institute of Technology
207

Joseph Loscalzo, MD, PhD

Chair of the Department of Medicine and Physician-in-Chief at Brigham and Women’s Hospital (BWH) Hersey Professor of the Theory and Practice of Medicine at Harvard Medical School (HMS)
208

Werner Meier

Former Vice President of Biologics Drug Discovery, Biogen Inc.
209

Bruce Tidor, PhD

Professor of Biological Engineering and Computer Science, Massachusetts Institute of Technology
210

Mike Yaffe, MD PhD

David H. Koch Professor of Biology and Biological Engineering, Massachusetts Institute of Technology Director of Clinical Outreach, Koch Institute for Integrative Cancer Research Senior Associate Member, Broad Institute Attending Surgeon, Beth Israel Deaconess Medical Center